
Capricor Therapeutics Inc (CAPR) is an excellent investment, but the stock is overvalued/undervalued right now
While Capricor Therapeutics Inc has underperformed by -2.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance,